If the current pandemic has taught us anything, it is to be resilient. It is no secret that businesses, big and small, are grappling with unfavourable situations, be it lack of labour, disturbed supply chain or disrupted logistic. Nonetheless, companies with strong fundamentals are able to minimise the coronavirus pandemic\u2019s impact on their businesses.<\/p>\n\n\n\n
Others entities manufacturing essential products are also sailing through the adversities. But there is a distinct set of companies that is blessed with a situational advantage with what\u2019s happening on the Indo-China front. Rossari Biotech is one such company. The company recently went live and its stock was listed at an attractive premium, for all the right reasons. That\u2019s what we will see in this article.<\/p>\n\n\n\n
This article covers:<\/strong><\/p>\n\n\n\n Introduction to Rossari Biotech IPO<\/a><\/p>\n\n\n\n An overview of the company that Rossari Biotech is<\/a><\/p>\n\n\n\n Operations of Rossari Biotech<\/a><\/p>\n\n\n\n Who are Rossari Biotech\u2019s competitors?<\/a><\/p>\n\n\n\n Highlights of Rossari Biotech IPO<\/a><\/p>\n\n\n\n Rossari Biotech IPO details<\/a><\/p>\n\n\n\n How does Rossari Biotech plan to use the IPO funds?<\/a><\/p>\n\n\n\n How did the IPO perform?<\/a><\/p>\n\n\n\n Rossari Biotech\u2019s financials and valuations<\/a><\/p>\n\n\n\n Impact of coronavirus on Rossari Biotech<\/a><\/p>\n\n\n\n What are the prospects of Rossari Biotech?<\/a><\/p>\n\n\n\n Conclusion<\/a><\/p>\n\n\n\n Table of Contents<\/p>\n<\/span><\/div>\n